SCHEMBL4024156

SCHEMBL4024156

CCCCCCCCCCCCCCC(CCCCCCCCCCCCCC)CC(O)(O)O

nearest known ligand 0.56

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.56
FDPS P14324 4/20 0.44
GPR84 Q9NQS5 4/20 0.40
SPHK1 Q9NYA1 1/20 0.40
FFAR1 O14842 1/20 0.40
ALDH1A1 P00352 1/20 0.39
MAPT P10636 1/20 0.39
LCK P06239 1/20 0.39
PPARD Q03181 1/20 0.39
ZDHHC20 Q5W0Z9 1/20 0.39
ZDHHC2 Q9UIJ5 1/20 0.39
DNM1 Q05193 1/20 0.39
TSHR P16473 1/20 0.38
THRB P10828 1/20 0.38
HSPD1 P10809 1/20 0.38
BLM P54132 1/20 0.38
HSPE1 P61604 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4021050 0.88 LMNA (0.45) LMNAFFAR1MAPTPPARDBLM
SCHEMBL15775240 0.87 LMNA (0.48) LMNAFDPSGPR84SPHK1FFAR1
SCHEMBL10457247 0.84 LMNA (0.54) LMNAFDPSGPR84SPHK1FFAR1
SCHEMBL12477841 0.80 LMNA (0.50) LMNAFDPSGPR84SPHK1FFAR1
SCHEMBL5176712 0.80 LMNA (0.50) LMNAFDPSGPR84SPHK1FFAR1
SCHEMBL29286434 0.80 LMNA (0.50) LMNAFDPSGPR84SPHK1FFAR1
SCHEMBL25907082 0.78 LMNA (0.52) LMNAFDPSGPR84SPHK1FFAR1
SCHEMBL28493573 0.77 LCK (0.45) LMNAFDPSGPR84SPHK1FFAR1
SCHEMBL24920054 0.76 LMNA (0.50) LMNAFDPSGPR84MAPTDNM1
SCHEMBL20809768 0.76 LMNA (0.50) LMNAFDPSGPR84MAPTDNM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2059257-A2 USE OF GLYCOLIPIDS AS ADJUVANTS Helmholtz-Zentrum für Infektionsforschung GmbH (DE) 2009-05-20 EP disclosed
WO-2008028667-A2 USE OF GLYCOLIPIDS AS ADJUVANTS Helmholtz-Zentrum für Infektionsforschung GmbH (DE) 2008-03-13 WO disclosed